These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11098421)

  • 1. Use of venlafaxine in other psychiatric disorders.
    Ninan PT
    Depress Anxiety; 2000; 12 Suppl 1():90-4. PubMed ID: 11098421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of venlafaxine treatment for ADHD in a child.
    Pleak RR; Gormly LJ
    Am J Psychiatry; 1995 Jul; 152(7):1099. PubMed ID: 7793453
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics.
    Park P; Caballero J; Omidian H
    Ann Pharmacother; 2014 Jan; 48(1):86-92. PubMed ID: 24259607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venlafaxine in the treatment of anxiety disorders.
    Katzman M
    Expert Rev Neurother; 2004 May; 4(3):371-81. PubMed ID: 15853535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
    Liebowitz MR; Gelenberg AJ; Munjack D
    Arch Gen Psychiatry; 2005 Feb; 62(2):190-8. PubMed ID: 15699296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of venlafaxine in the treatment of obsessive-compulsive disorder.
    Phelps NJ; Cates ME
    Ann Pharmacother; 2005 Jan; 39(1):136-40. PubMed ID: 15585743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venlafaxine in obsessive-compulsive disorder.
    Yaryura-Tobias JA; Neziroglu FA
    Arch Gen Psychiatry; 1996 Jul; 53(7):653-4. PubMed ID: 8660133
    [No Abstract]   [Full Text] [Related]  

  • 9. Venlafaxine in treatment resistant obsessive-compulsive disorder.
    Narayanaswamy JC; Viswanath B; Cherian AV; Math SB; Reddy YC
    J Neuropsychiatry Clin Neurosci; 2014; 26(3):E44-5. PubMed ID: 25093787
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.
    Liebowitz MR; Mangano RM; Bradwejn J; Asnis G;
    J Clin Psychiatry; 2005 Feb; 66(2):238-47. PubMed ID: 15705011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venlafaxine treatment of obsessive-compulsive disorder: case reports.
    Marazziti D
    CNS Spectr; 2003 Jun; 8(6):421-2. PubMed ID: 12858131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venlafaxine for treatment of obsessive-compulsive disorder.
    Ananth J; Burgoyne K; Smith M; Swartz R
    Am J Psychiatry; 1995 Dec; 152(12):1832. PubMed ID: 8526258
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of obsessive-compulsive disorder with venlafaxine.
    Grossman R; Hollander E
    Am J Psychiatry; 1996 Apr; 153(4):576-7. PubMed ID: 8599411
    [No Abstract]   [Full Text] [Related]  

  • 14. Venlafaxine treatment of panic disorder: a case series.
    Geracioti TD
    J Clin Psychiatry; 1995 Sep; 56(9):408-10. PubMed ID: 7665539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
    Dell'Osso B; Nestadt G; Allen A; Hollander E
    J Clin Psychiatry; 2006 Apr; 67(4):600-10. PubMed ID: 16669725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia.
    VanderWeide LA; Smith SM; Trinkley KE
    J Clin Pharm Ther; 2015 Feb; 40(1):1-6. PubMed ID: 25294655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.
    Denys D; van der Wee N; van Megen HJ; Westenberg HG
    J Clin Psychopharmacol; 2003 Dec; 23(6):568-75. PubMed ID: 14624187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of venlafaxine extended release formulation on the clinical management of patients].
    Carrasco JL; Díaz-Marsá M; López-Ibor JJ
    Actas Esp Psiquiatr; 2005; 33(3):147-53. PubMed ID: 15918081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.
    Kroenke K; Messina N; Benattia I; Graepel J; Musgnung J
    J Clin Psychiatry; 2006 Jan; 67(1):72-80. PubMed ID: 16426091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders.
    Altamura AC; Pioli R; Vitto M; Mannu P
    Int Clin Psychopharmacol; 1999 Jul; 14(4):239-45. PubMed ID: 10468317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.